Study of SPARC1103 in Subjects With Spasticity
NCT02027025
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class
Conditions
Spasticity
Interventions
DRUG:
SPARC1103 low dose
DRUG:
SPARC1103 high dose
DRUG:
SPARC Placebo
Sponsor
Sun Pharma Advanced Research Company Limited